We analyzed bipolar carrier transport characteristics of diarylamino-substituted heterocyclic compounds (DAHCs) having benzene, pyridine, pyrimidine, or triazine electron-accepting core units and carbazole or β-naphthylamine as electron-donating substituents. The highest occupied molecular and lowest unoccupied molecular orbital levels, carrier injection, and transport characteristics were systematically controlled by changing combinations of the core and substituent units. By analyzing electroluminescence spectra as a probe in four kinds of organic light emitting diode (OLED) structures, we found that the carrier transport characteristics of DAHCs significantly change depending on device structure. We concluded that all DAHCs have bipolar carrier transport characteristics, that is, DAHCs intrinsically possess both hole and electron mobilities that are based on unique molecular structures having both electron-donating and -accepting units. We also demonstrated that carrier injection barriers between DAHCs and adjacent carrier transport layers virtually control the appearance of bipolar characteristics in OLEDs.
We studied the relaxation of electroluminescence roll-off characteristics by changing the dopant concentration and thickness of the emitting layer in organic blue electrophosphorescence diodes composed of a 2,6-dicarbazolo-1,5-pyridine host doped with iridium(III)-bis[(4,6-di-fluorophenyl)-pyridinato-N,C 2 ]picolinate. Analyzing the roll-off characteristics using the theoretical models of triplet-triplet annihilation and triplet-polaron annihilation (TPA), we found that the roll-off characteristics of these devices were determined primarily by TPA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.